$Gyre Therapeutics (GYRE.US)$ In the content that the wise p...
In the content that a wise person asked GPT Sensei about,
There is a possibility that fundraising through 'Mixed Shelf' may be used for third-party allocation and capital increase for partner companies.
'Mixed Shelf' is a flexible mechanism for issuing multiple types of securities, so companies may consider implementing third-party allocations and capital increases for partners as part of fundraising. Specifically, companies can allocate common or preferred shares to partner companies from the previously registered 'Mixed Shelf' with the SEC, promoting strategic partnerships and obtaining funds tailored to specific business purposes.
By utilizing the registration framework of 'Mixed Shelf,' companies can dynamically choose fundraising methods, making it a suitable approach for third-party increases for partnerships or strategic partnerships.
Expecting a skyrocketing surge 🚀 used for third-party allocation with a major pharmaceutical company. m(__)m
There is a possibility that fundraising through 'Mixed Shelf' may be used for third-party allocation and capital increase for partner companies.
'Mixed Shelf' is a flexible mechanism for issuing multiple types of securities, so companies may consider implementing third-party allocations and capital increases for partners as part of fundraising. Specifically, companies can allocate common or preferred shares to partner companies from the previously registered 'Mixed Shelf' with the SEC, promoting strategic partnerships and obtaining funds tailored to specific business purposes.
By utilizing the registration framework of 'Mixed Shelf,' companies can dynamically choose fundraising methods, making it a suitable approach for third-party increases for partnerships or strategic partnerships.
Expecting a skyrocketing surge 🚀 used for third-party allocation with a major pharmaceutical company. m(__)m
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
米国株はGYRE、日本株はGNIをメイン。
NPCは第二の野村マイクロ銘柄かな。
APDNのサル痘🚀に期待。
PULMは静観でin待ち中。
81Followers
4Following
363Visitors
Follow
たかひと_1023 : There's no choice but to bet on it
待ち焦がれる男 OP : I breathed a sigh of relief
Underwater, I have long been selecting a partner (major company) and I see progress from the state where the draft has been completed. Next is...
Finally starting to feel the excitement, right?